Screener
Rigel Pharmaceuticals RIGL Net debt
Discontinued — last reported Q1 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Rigel Pharmaceuticals’s reported figures.
The source filing: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001034842-26-000032
FAQ
- What is Rigel Pharmaceuticals's net debt?
- Rigel Pharmaceuticals (RIGL) reported net debt of $43.9M in Q1 2026.
- How has Rigel Pharmaceuticals's net debt changed year-over-year?
- Rigel Pharmaceuticals's net debt increased by 198.7% year-over-year, from -$44.47M to $43.9M.
- What is the long-term trend for Rigel Pharmaceuticals's net debt?
- Over 5 years (2020 to 2025), Rigel Pharmaceuticals's net debt has grown at a 31.1% compound annual growth rate (CAGR), from -$11.07M to $42.87M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Rigel Pharmaceuticals's net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude